Myostatin inhibitors and myostatin deletion in rodents has not only shown to increase muscle mass [240,241], but also protect against the negative effects of obesity by preventing insulin resistance and accumulation of body fat, and enhancing fatty acid oxidation [239,242,243,244]. Here, MSTN is linked to obesity due to melanocortin 4 receptor deficiency.